← FDA Drug Approvals (Drugs@FDA)
SITAGLIPTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMACEUTICALS INC · Approved 2025-03-06
Drug application
- FDA Application #
ANDA216337- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SITAGLIPTIN
- Generic name
- Sitagliptin
- Active ingredients
- SITAGLIPTIN
- Dosage form
- TABLET
- Route
- FILM COATED
- Marketing status
- None (Tentative Approval)
- Sponsor
- SCIEGEN PHARMACEUTICALS INC
- First approval
- 2025-03-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown